Login

From the Helm: Lindsay Partridge on Brickworks' Growth and Dividend Success | Lindsay Partridge - CEO of brickworks ltd 00:10:00

Share On Facebook Share On Twitter

Lindsay Partridge is the CEO of brickworks ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Why Bitcoin is Not a Hedge Against Inflation|Kyle Samani,Co-Founder and Managing Partner,Multicoin Capital
00:10:00
A Night of Melody and Passion: An Evening with Isabel
00:10:00
Own Real Estate Without the Hassle when real state is hassle|Ellis Hammond,CEO,Symphony Capital LLC
00:10:00
Next-generation PDT that is more effective and overcomes the many shortcomings|Mr Thian Chew,CEO,Invion Ltd
00:10:00
"Maximizing Opportunities Under the Inflation Reduction Act: Strategic Insights for Businesses to Leverage New Economic Policies"
00:10:00
Il Capitale Naturale: Preservazione e Rigenerazione con Lombard Odier Investment Managers
00:00:00
Evgen Pharma "delighted" with cash position after promising first half - Dr Huw Jones , CEO, Evgen Pharma
00:10:00
PNC CEO Discusses Strategic BlackRock Sale and Future Financial Plans Amid Economic Uncertainty | Bill Demchak, CEO, PNC Financial Services .
00:10:00
Interview with Raymond Racaza of Xurpas | Jonathan Gerard A. Gurango, CEO, Xurpas IncX:PHS
00:10:00
Jennifer Terry on Jet Capital's Support, Culture, and Work Environment
00:10:00
Ludlow Manufacturing: Powering Steel Innovation | Alex Waser - CEO of bystronic ag
00:10:00
The Role of Technology in Modern Family Offices: Insights from Greg Harris | Greg Harris - Partner and Head of Family Office – British Islands, Stonehage

© 2017 - Neuhu+